Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset.
To read more About benefits and Risks go to https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19
Can anyone get a Paxlovid prescription? The FDA authorized Paxlovid for people ages 12 and older who weigh at least 88 pounds. But in order to qualify for a prescription, you must also have had a positive COVID-19 test result and be at high risk for developing severe COVID-19.
To check if you qualify for a prescription simply call 📞 your Doctor or just fill out this form and we'll be glad to help you. https://form.jotform.com/221178954020149
We love our customers, so feel free to visit during normal business hours.
9320 US-19 hwy, Port Richey, FL 34668, United States
Open today | 09:00 am – 05:00 pm |
Copyright © 2022 Embassy Compounding Pharmacy - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.